查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869748

生物指示器市場規模、佔有率和趨勢分析報告：按產品、方法、最終用途、地區和細分市場預測（2025-2033 年）

Biological Indicators Market Share, Share & Trends Analysis Report By Product (Self-Contained, Strips, Cards / Rapid Readout BIs), By Method (Steam Sterilization, Ethylene Oxide Sterilization), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

生物指示器市場摘要

2024年全球生物指示器市場規模估計為5.348億美元，預計2033年將達到11.1億美元。

預計從 2025 年到 2033 年，該市場將以 8.59% 的複合年成長率成長。這一市場成長是由醫療保健、製藥和食品產業對消毒和感染控制日益重視所推動的。

醫院感染（HAI）日益受到關注，以及對滅菌流程檢驗的嚴格監管要求，推動了對可靠、快速的生物指示器解決方案的需求。此外，快速讀數和自動化技術的進步，以及新興市場對滅菌方法的日益普及，也進一步促進了市場成長。

嚴格的監管要求在推動生物指示器產業發展方面發揮關鍵作用。世界各地的衛生監管機構都要求醫療設備、製藥和生物技術等產業的滅菌流程檢驗。生物指示器是驗證滅菌效果的黃金標準，也是達到合規性的關鍵。例如，美國食品藥物管理局(FDA) 要求醫療設備製造商根據《聯邦法規》第 21 篇第 820 部分（品質系統法規）證明其滅菌檢驗符合要求。同時，歐洲藥品管理局 (EMA) 和 ISO 11138 標準也為生物指示器在無菌保證中的應用制定了具體標準。同樣，基於生物指示器的滅菌藥品和器械檢驗對於製藥企業遵守良好生產規範 (GMP) 至關重要。這些嚴格的法規結構確保了患者安全和產品可靠性，從而在關鍵的醫療保健和生命科學領域創造了對生物指示器的穩定需求。

隨著醫療機構日益重視加強感染控制和消毒措施，醫院感染（HAI）的不斷上升趨勢成為推動生物指示器產業發展的主要因素。世界衛生組織發布的《2024年全球感染預防與控制報告》對約400項研究進行了大規模系統性回顧，估計到2023年，全球醫院感染的盛行率將達到約14%。此外，2022/2023年在28個歐盟/歐洲經濟區成員國和三個西巴爾幹國家/地區開展的一項歐洲定點盛行率調查顯示，至少發生過一次醫院感染的患者已調整的盛行率為8%。醫院感染發生率的上升凸顯了可靠消毒檢驗的重要性，並推動了對生物指示劑的需求，以確保在預測期內消毒流程的有效性。

全球外科手術數量的不斷成長，從擇期手術到複雜的器官移植，推動了對生物指示器產業的需求。醫院和手術中心手術量的增加，導致需要檢驗的滅菌流程的可重複使用器械的常規使用量激增。這種激增造成了吞吐量壓力，提高了品質和合規標準，並促使醫療機構實施嚴格的滅菌檢驗方法。根據2024年手術統計數據，2024年預計將進行約1,585,878例美容手術，比2023年增加1%。同時，同期重組手術量將增加2%。手術介入的持續成長凸顯了生物指標在確保滅菌流程有效性和保障病人安全的重要性。

技術創新正顯著改變市場格局，顯著提升了滅菌檢驗的效率、準確性和合規性。例如，快速檢測指示劑等創新技術已將確認滅菌效果所需的時間從數天縮短至數小時，從而加快了繁忙醫療機構的設備週轉速度。以Solventum公司為例，該公司於2025年6月推出了Attest超快速氣化過氧化氫（VH2O2）透明挑戰包，這是一款即用型解決方案，將兩種先前已獲FDA已通過核准的指示劑整合到一個測試系統中。此挑戰包將用於檢驗微生物去活化的生物指示劑（BI）和用於驗證滅菌器性能的化學指示劑（CI）組合在一個透明的一次性容器中，從而簡化並可靠地驗證了滅菌效果。

「透過創新，可以更輕鬆、更可靠、更快速地對所有滅菌模式下的每個滅菌批次進行監控，這將使醫療機構能夠持續保持最高的患者安全標準，同時滿足現代無菌處理部門不斷提高的生產力需求，」醫療保健無菌處理協會 (HSPA) 前任主席 Sharon Green-Golden 表示。

「在生死攸關的消毒環境中，速度和準確性都至關重要，」公司感染預防和外科解決方案業務部高級副總裁道格·巴特利特表示，「Solventum 的創新技術為專業人員提供直覺、前沿的資源，幫助他們保護患者健康。這體現了我們致力於在關鍵環境中持續支持高標準護理的承諾。」

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 生物指示器市場變數、趨勢與範圍

  • 市場體系展望
    • 附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 生物指示器市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 生物指示器市場：產品估算與趨勢分析

  • 細分儀表板
  • 生物指示器市場：產品差異分析及市場佔有率（2024 年及 2033 年）
  • 自足式的
  • 條
  • 卡/高速讀取 BI
  • 其他

第5章 生物指示器市場：方法論估算與趨勢分析

  • 細分儀表板
  • 生物指示器市場：方法學差異分析及市場佔有率（2024 年及 2033 年）
  • 蒸氣滅菌
  • 環氧乙烷滅菌
  • 過氧化氫滅菌
  • 放射線殺菌
  • 乾熱滅菌

第6章：生物指示器市場：終端用途估算與趨勢分析

  • 細分儀表板
  • 生物指示器市場：最終用途變化分析及市場佔有率（2024 年和 2033 年）
  • 醫院和診所
  • 門診手術中心（ASC）和牙科診所
  • 生物製藥和生物技術公司
  • 醫療設備製造商
  • 合約滅菌服務供應商
  • 研究和學術機構
  • 其他用途

第7章 生物指示器市場：按產品、方法和最終用途分類的區域估算和趨勢分析

  • 區域展望
  • 生物指示器市場：區域差異分析及市場佔有率（2024 年及 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • STERIS plc.
    • Solventum
    • Getinge
    • Mesa Laboratories, Inc.
    • 3M
    • Terragene SA
    • Propper Manufacturing Co., Inc.
    • Tuttnauer
    • Ecolab Inc.
    • HWAndersen Products Ltd.
    • MATACHANA GROUP
    • LISTER BIOMEDICAL CO.,LTD
    • Liofilchem Srl
    • Steelco SpA
    • Zhejiang Tailin Bioengineering Co., Ltd.
    • Cole-Parmer Instrument Company, LLC（Antylia Scientific）
    • Anhui Tianrun Medical Packaging Materials Co., Ltd.
    • Medline Industries, LP.
    • True Indicating
  • 公司市佔率分析，2024 年
Product Code: GVR-4-68040-757-3

Biological Indicators Market Summary

The global biological indicators market size was estimated at USD 534.80 million in 2024 and is projected to reach USD 1.11 billion by 2033, growing at a CAGR of 8.59% from 2025 to 2033. The growth of the market is attributed due to the growing emphasis on sterilization and infection control across healthcare, pharmaceutical, and food industries.

Increasing concerns over hospital-acquired infections (HAIs) and stringent regulatory requirements for validating sterilization processes are boosting demand for reliable and rapid BI solutions. In addition, advancements in rapid-readout and automation technologies, coupled with rising adoption of sterilization methods in emerging markets, are further accelerating the growth of the market.

Stringent regulatory requirements play a pivotal role in driving the biological indicators industry, as global health authorities mandate the validation of sterilization processes across industries such as medical devices, pharmaceuticals, and biotechnology. Biological indicators are the gold standard for confirming sterilization efficacy, making them a necessity for compliance. For instance, the U.S. Food and Drug Administration (FDA) requires medical device manufacturers to demonstrate sterilization validation under 21 CFR Part 820 (Quality System Regulation), while the European Medicines Agency (EMA) and the ISO 11138 standard outline specific criteria for biological indicator use in sterilization assurance. Similarly, compliance with Good Manufacturing Practices (GMP) in pharmaceuticals necessitates biological indicator-based validation for sterilized drug products and equipment. These strict regulatory frameworks ensure patient safety and product reliability, fueling consistent demand for biological indicators across critical healthcare and life sciences sectors.

The rising burden of hospital-acquired infections (HAIs) is a key factor driving the growth of the biological indicators industry, as healthcare facilities are increasingly focusing on strengthening infection control and sterilization practices. According to the WHO's Global Report on Infection Prevention and Control 2024, a large-scale systematic review of nearly 400 studies estimated the global prevalence of HAIs at around 14% in 2023. Furthermore, a European point prevalence survey conducted in 2022/2023 across 28 EU/EEA countries and three Western Balkan nations/territories reported an adjusted prevalence of 8% for patients with at least one HAI. This growing incidence of HAIs underscores the critical need for reliable sterilization validation, fueling the demand for biological indicators to ensure the effectiveness of sterilization processes over the forecast period.

The global rise in surgical procedures, ranging from elective operations to complex organ transplants, is significantly driving demand in the biological indicators industry. The growing procedural load in hospitals and surgical centers has led to a sharp increase in the daily use of reusable instruments that must undergo validated sterilization. This surge creates volume pressures and raises the bar for quality and compliance, pushing healthcare facilities to adopt stringent sterilization validation practices. According to the 2024 Procedural Statistics Release, approximately 1,585,878 cosmetic surgeries were performed in 2024, marking a 1% increase from 2023, while reconstructive procedures rose by 2% over the same period. The steady growth in surgical interventions highlights the critical need for biological indicators to ensure the effectiveness of sterilization processes and safeguard patient safety.

Technological advancements significantly shape the market by improving efficiency, accuracy, and compliance in sterilization validation. Innovations such as rapid-readout indicators have reduced the time required to confirm sterilization efficacy from several days to a few hours, accelerating instrument turnaround in busy healthcare facilities. For instance, in June 2025, Solventum introduced its Attest Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack, a ready-to-use solution that combines two previously FDA-cleared indicators into one test system. The pack integrates a biological indicator (BI) to confirm microbial inactivation and a chemical indicator (CI) to verify sterilizer performance, all within a transparent, single-use container for simplified and reliable sterilization validation.

"Innovations that make every load monitoring easier to adopt, more reliable, and faster across sterilization modalities empower healthcare facilities to consistently uphold the highest patient safety standards while supporting the increasing productivity demand of modern sterile processing departments," said Sharon Greene-Golden, past president of the Healthcare Sterile Processing Association (HSPA).

"In the high-stakes environment of sterile processing where patients' lives are at stake, both speed and accuracy are non-negotiable," said Doug Bartlett, senior vice president of the company's Infection Prevention & Surgical Solutions business. "Solventum innovations equip dedicated professionals with intuitive, cutting-edge resources that help them to safeguard patient health, reflecting our drive to continually support elevated standards of care in critical settings."

Global Biological Indicators Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biological indicators market report based on product, method, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Self-Contained (Vials/Ampoules)
  • Strips
  • Cards / Rapid Readout BIs
  • Others
  • Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Steam Sterilization
  • Ethylene Oxide Sterilization
  • Hydrogen Peroxide Sterilization
  • Irradiation Sterilization (Gamma, E-beam)
  • Dry Heat Sterilization
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics (CSSD / Infection Control Units)
  • Ambulatory Surgery Centers (ASCs) & Dental Clinics
  • Biopharma & Biotech Companies
  • Medical Device Manufacturers
  • Contract Sterilization Service Providers
  • Research & Academic Institutes
  • Other End Uses
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Third Party Perspective
    • 1.3.5. Primary research
    • 1.3.6. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
  • 1.7. Approach 1: Commodity flow approach
    • 1.7.1 Volume price analysis (Model 2)
  • 1.8. Approach 2: Volume price analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biological Indicators Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Healthcare-Associated Infections (HAIs)
      • 3.2.1.2. Stringent Regulatory Requirements and Standards
      • 3.2.1.3. Growth in Surgical Procedures and Healthcare Infrastructure
      • 3.2.1.4. Technological Innovation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Advanced Indicators and Supporting Systems
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Integration with Digital/IoT & Automation
      • 3.2.3.2. Emerging Market Expansion
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Competition from Alternative & Less Expensive Technologies
  • 3.3. Biological Indicators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power of Suppliers
      • 3.3.1.2. Bargaining Power of Buyers
      • 3.3.1.3. Threat of Substitutes
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. Biological Indicators Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biological Indicators Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Self-Contained
    • 4.3.1. Self-Contained Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Strips
    • 4.4.1. Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Cards / Rapid Readout BIs
    • 4.5.1. Cards / Rapid Readout BIs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Biological Indicators Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biological Indicators Market: Method Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Steam Sterilization
    • 5.3.1. Steam Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Ethylene Oxide Sterilization
    • 5.4.1. Ethylene Oxide Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Hydrogen Peroxide Sterilization
    • 5.5.1. Hydrogen Peroxide Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Irradiation Sterilization
    • 5.6.1. Irradiation Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Dry Heat Sterilization
    • 5.7.1. Dry Heat Sterilization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Biological Indicators Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biological Indicators Market: End Use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals & Clinics
    • 6.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ambulatory Surgery Centers (ASCs) & Dental Clinics
    • 6.4.1. Ambulatory Surgery Centers (ASCs) & Dental Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biopharma & Biotech Companies
    • 6.5.1. Biopharma & Biotech Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Medical Device Manufacturers
    • 6.6.1. Medical Device Manufacturers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Contract Sterilization Service Providers
    • 6.7.1. Contract Sterilization Service Providers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Research & Academic Institutes
    • 6.8.1. Research & Academic Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Other End Uses
    • 6.9.1. Other End Uses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Biological Indicators Market: Regional Estimates & Trend Analysis by Product, Method, End Use

  • 7.1. Regional Outlook
  • 7.2. Biological Indicators Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Biological Indicators Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. STERIS plc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Solventum
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Getinge
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Mesa Laboratories, Inc.
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. 3M
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Terragene S.A.
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Propper Manufacturing Co., Inc.
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Tuttnauer
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Ecolab Inc.
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. H.W.Andersen Products Ltd.
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. MATACHANA GROUP
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. LISTER BIOMEDICAL CO.,LTD
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Product Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Liofilchem S.r.l.
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Product Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Steelco S.p.A.
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Product Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Zhejiang Tailin Bioengineering Co., Ltd.
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Product Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Cole-Parmer Instrument Company, LLC (Antylia Scientific)
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Product Benchmarking
      • 8.2.16.4. Strategic Initiatives
    • 8.2.17. Anhui Tianrun Medical Packaging Materials Co., Ltd.
      • 8.2.17.1. Company Overview
      • 8.2.17.2. Financial Performance
      • 8.2.17.3. Product Benchmarking
      • 8.2.17.4. Strategic Initiatives
    • 8.2.18. Medline Industries, LP.
      • 8.2.18.1. Company Overview
      • 8.2.18.2. Financial Performance
      • 8.2.18.3. Product Benchmarking
      • 8.2.18.4. Strategic Initiatives
    • 8.2.19. True Indicating
      • 8.2.19.1. Company Overview
      • 8.2.19.2. Financial Performance
      • 8.2.19.3. Product Benchmarking
      • 8.2.19.4. Strategic Initiatives
  • 8.3. Company Market Share Analysis, 2024

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global biological indicators market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 5 Global biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 9 North America biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 12 U.S. biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 15 Canada biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 18 Mexico biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 22 Europe biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 25 UK biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 28 Germany biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 30 France biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 31 France biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 34 Italy biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 37 Spain biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 40 Denmark biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 43 Sweden biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 46 Norway biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 52 China biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 53 China biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 56 Japan biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 58 India biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 59 India biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 62 South Korea biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 65 Australia biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 68 Thailand biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 72 Latin America biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 75 Brazil biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 78 Argentina biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA biological indicators market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 82 MEA biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 85 South Africa biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 91 UAE biological indicators market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait biological indicators market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait biological indicators market, by method, 2021 - 2033 (USD Million)
  • Table 94 Kuwait biological indicators market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Biological indicators market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Biological indicators market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by distribution channel
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Self-contained market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Cards / rapid readout Bis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Steam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Ethylene oxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Hydrogen peroxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Irradiation sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Dry heat sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Ambulatory surgery centers (ASCs) & dental clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Biopharma & biotech companies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Medical device manufacturers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Contract sterilization service providers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Research & academic institutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Other end uses market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Biological indicators market: Regional key takeaways (USD Million)
  • Fig. 29 Biological indicators market: Regional outlook, 2024 & 2033 (USD Million)
  • Fig. 30 North America biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Canada biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Mexico biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 UK biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Germany biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 France biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Spain biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Italy biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Sweden biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Norway biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Denmark biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Asia Pacific biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 China biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Japan biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 India biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 South Korea biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Australia biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Thailand biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Latin America biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Brazil biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Argentina biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Middle East and Africa biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 South Africa biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Saudi Arabia biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 UAE biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Kuwait biological indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 List of key emerging companies
  • Fig. 59 Company market share analysis, 2024
  • Fig. 60 Market differentiators
  • Fig. 61 Competitive dashboard analysis
  • Fig. 62 Regional network map